Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03276468
Brief Title: Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

First Submitted : September 7, 2017
First Submitted that Met QC Criteria : September 7, 2017
First Posted : September 8, 2017

Last Update Submitted that Met QC Criteria : January 6, 2020
Last Update Posted : January 7, 2020